|
|
| |
Diagnostics & Others
|
| |
INJEX -
The injection without needle
Fear of needle injections is
widespread and the associated problems are numerous: crying children, long
treatments, no or incorrectly applied but necessary therapies. This
frequently results in serious secondary diseases that not only stress the
patient but all of the associated aspects such as insurance companies and
medication budgets.
INJEX EUROPE has developed an attractive
alternative:
INJEX. "The
injection without needle"
INJEX allows for easy subcutaneous injections.
The benefits at a
glance:
- injection without needle
- virtually painless
- veritably tissue preserving
- strictly subcutaneous injection
- fast, easy and safe in use and effect
- individual dosing of medications
- no risk of infection as a result of needle-stick injuries
- reduces fear as a result virtually painfree injection without needle
- compact and can be used everywhere
- economical
- Can be prescribed as medical aid (in Germany)
- Relieves physicians' medication budget (in Germany)
All
conditions for cost reimbursement by health insurance companies according
to § 139 Article 2 SGB V (German Code of Social Law, Volume 5) have been
fulfilled since May 2002. Starting immediately,INJEX - together with the consumables -
can be prescribed and the respective health insurance can use the assigned
medical aid number (No. 03.99.10.0001) to reimburse
costs.
CE Certification
INJEX is CE certified (CE 0482) within the
European Union for the subcutaneous administration of medication suitable
for jet injection. Since September 1999,INJEX produced in Germany and categorised
as an II B product according to the medical product law has been
certified.
The first field of application was the use of U-100 insulin
for diabetics. By now, the areas of application forINJEX has been expanded greatly. INJEX EUROPE strives to expand the use of INJEX to cover as many
fields of application as possible.
|
|
| |
|
